Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-22

Clinical Trial Update: Metformin Treatment in Progressive Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluated metformin as a treatment for progressive multiple sclerosis, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis | EARLY_Phase 1 | Status: COMPLETED